N-acetylation genotype and risk of severe reactions to sulphonamides in AIDS patients - PMC

Skip to main content

letter

. 1994 Dec;38(6):581–582. doi: 10.1111/j.1365-2125.1994.tb04401.x

581

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Carr A., Gross A. S., Hoskins J. M., Penny R., Cooper D. A. Acetylation phenotype and cutaneous hypersensitivity to trimethoprim-sulphamethoxazole in HIV-infected patients. AIDS. 1994 Mar;8(3):333–337. doi: 10.1097/00002030-199403000-00006. [DOI] [PubMed] [Google Scholar]
Gordin F. M., Simon G. L., Wofsy C. B., Mills J. Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1984 Apr;100(4):495–499. doi: 10.7326/0003-4819-100-4-495. [DOI] [PubMed] [Google Scholar]
Grant D. M. Molecular genetics of the N-acetyltransferases. Pharmacogenetics. 1993 Feb;3(1):45–50. doi: 10.1097/00008571-199302000-00005. [DOI] [PubMed] [Google Scholar]
Lee B. L., Wong D., Benowitz N. L., Sullam P. M. Altered patterns of drug metabolism in patients with acquired immunodeficiency syndrome. Clin Pharmacol Ther. 1993 May;53(5):529–535. doi: 10.1038/clpt.1993.66. [DOI] [PubMed] [Google Scholar]
Shear N. H., Spielberg S. P., Grant D. M., Tang B. K., Kalow W. Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Intern Med. 1986 Aug;105(2):179–184. doi: 10.7326/0003-4819-105-2-179. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES